Showing results (261-270 of 901) with videos related to
Sort By:
Pageof 91
Zeitschrift Fur Gastroenterologie|May 13, 2025
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R)Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-RegistryHartwig Klinker, Uwe Naumann, Martin Rössle, et al.Open Forum Infectious Diseases|August 11, 2021
Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction-A Real-world ExperienceLisa Sandmann, Julian Deppe, Christoph Beier, et al.Hepatology International|October 3, 2023
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfectionAnika Wranke, Benjamin Heidrich, Katja Deterding, et al.Journal of Virology|August 14, 2015
Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and PathogenesisLaurie L Kenney, Markus Cornberg, Alex T Chen, et al.Viruses|October 27, 2022
Cross-Reactive T Cell Response Exists in Chronic Lymphocytic Choriomeningitis Virus Infection upon Pichinde Virus ChallengeJasmin Mischke, Sebastian Klein, Austin Seamann, et al.Bioinformatics Advances|December 11, 2024
MeTEor: an R Shiny app for exploring longitudinal metabolomics dataGordon Grabert, Daniel Dehncke, Tushar More, et al.Plos One|August 3, 2019
Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosisMarkus Kimmann, Tammo Lambert Tergast, Marie Schultalbers, et al.Journal of Hepatology|August 31, 2016
The role of quantitative hepatitis B surface antigen revisitedMarkus Cornberg, Vincent Wai-Sun Wong, Stephen Locarnini, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2022
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patientsValerie Ohlendorf, Maximilian Wübbolding, Paul Gineste, et al.Pageof 91